Global investment firm Index Ventures announced the establishment of JinYi connect (Singapore) Fund in Singapore. This strategic move marks a significant leap forward for Index Ventures and JinYi connect , transforming them from "investors in the Asian market" to "builders and leaders of the Asian innovation ecosystem," injecting new momentum into the Asian biomedical innovation sector. As a core subsidiary of Index Ventures, JinYi connect will collaborate closely with JinYi connect (Singapore) Fund, leveraging this dual-core strategy to build a cross-border innovation network and jointly promote the high-quality development of the Asian healthcare technology industry.

The establishment of this Singapore-based fund is a key step in the three parties' deepening of their Asian strategy. It is understood that the new company will use Singapore as its core capital and strategic hub, fully leveraging the region's unique advantages as a wealth management center, technology hub, and biomedical powerhouse in Asia and globally to efficiently raise and precisely allocate global capital. Currently, cutting-edge fields such as AI+biomedicine and cell and gene therapy (CGT) are becoming core tracks for global medical innovation. The new company will focus on this core direction, accurately identifying and nurturing the next generation of medical technology innovation forces in Asia, providing capital empowerment and resource support for high-quality innovative projects in the industry.
A representative from Index Ventures stated that Singapore, with its sound financial regulatory system, abundant scientific research resources, and superior geographical advantages, has become an important hub connecting East and West markets, which aligns perfectly with the three parties' core vision of "connecting global capital and driving Asian biomedical innovation." This move is not only an extension at the capital level but also a crucial step in building an innovation ecosystem. By integrating global capital with local Asian innovation forces, it will effectively fill key gaps in the regional medical technology industry chain and accelerate the industrialization of cutting-edge technologies.
As a subsidiary of Index Ventures, JinYi connect and JinYi connect (Singapore) Fund will establish a deeply collaborative partnership.JinYi connect will leverage its years of experience in the Asian market to provide the Singaporean company with localized industry resources and market insights; JinYi connect(Singapore) Fund will focus on global capital raising and cross-border resource integration. This creates a complementary "local focus + global connectivity" model, jointly promoting the improvement and upgrading of the Asian innovation ecosystem.
Notably, this strategic upgrade will also drive an iterative upgrade of Index Ventures' capital operation model in Asia. Following the official establishment of JinYi connect (Singapore) Fund, Index Ventures will strengthen the synergy between the two core financial centers of Hong Kong and Singapore. Building on its Hong Kong business, it will add a strategic foothold in Singapore, achieving a dual-hub drive. This upgrade will establish an independent and professional dual-capital operation platform in a core Asian financial hub. This model upgrade will significantly improve capital allocation efficiency, enabling full-cycle, full-chain empowerment of Asian medical technology innovation projects.
As a major global hub for the biopharmaceutical industry, Singapore boasts a comprehensive industrial support system, top-tier research institutions, and an open policy environment, attracting numerous global biopharmaceutical companies and investment institutions. Index Ventures' decision to establish a fund company here sends a strong signal to the market: a long-term, deep, and professional commitment to the Asian market. Index Ventures (Singapore) Fund will fully leverage local industrial advantages to build a cross-border investment and commercialization network connecting East and West. On the one hand, it will help Asian innovative companies connect with global capital markets and technological resources; on the other hand, it will introduce advanced global technological concepts and industry experience to Asia, achieving mutual empowerment.

About JinYi connect : JinYi connect is a subsidiary of Index Ventures focusing on the digital economy. It specializes in providing enterprises with digital transformation solutions and industrial internet platform operations. With a strong presence in the Asian market, JinYi connect has established deep partnerships with numerous industry leaders, contributing to the digital upgrade of industries.